Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide Synthesis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106146359B reveals metal-free amide synthesis. Discover cost reduction in peptide manufacturing and high-purity intermediate supply chain solutions.
Patent CN107652355B reveals efficient liquid phase synthesis. Offers high purity and scalable production for cosmetic active ingredient supply chains globally.
Patent CN103483426A details a safer, high-yield synthesis of Caspofungin using substituted thiophenols, offering significant cost and purity advantages for pharmaceutical manufacturing.
Novel AM Resin method improves purity and yield for semaglutide manufacturing. Reduces impurities and simplifies purification for reliable supply chain partners.
Patent CN107880111B reveals a novel Glu-21 side-chain anchoring method for Liraglutide, enhancing coupling efficiency and purity for scalable manufacturing.
Patent CN107778350B details a high-yield solid-phase synthesis for Romidepsin, offering superior purity and cost reduction in pharmaceutical manufacturing.
Patent CN105753844A reveals convergent synthesis for Daclatasvir intermediates improving yield and atom economy. Discover supply chain advantages and cost reduction strategies.
Patent CN112574285B reveals a novel solid-liquid phase synthesis for disulfide-bonded polypeptides, offering high purity and simplified manufacturing for pharmaceutical intermediates.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Patent CN104710509B reveals low-temperature solid-phase synthesis for over 99% purity Eptifibatide, ensuring supply chain stability and reduced impurities for global buyers.
Novel solution-phase route for GHK and blue copper peptide eliminates expensive condensing agents, offering significant cost reduction and scalability for cosmetic manufacturers.
Novel solid-liquid hybrid method for Semaglutide fragments improves yield to 49% and purity to 99.9%, ensuring reliable supply chain.
Patent CN108218957B details a novel hybrid synthesis for AMG416, offering improved purity and reduced environmental impact for reliable pharmaceutical intermediate supply chains.
Patent CN109438363B reveals a liquid-phase high-purity synthesis method. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107827956A details solid-phase synthesis of Reniochalistatin E. Offers high purity and reduced racemization for reliable pharmaceutical intermediates supply chains.
Patent CN102020703A details a robust solid-phase synthesis for fatty acyl cyclic depsipeptides. This method offers high purity and scalability for antibiotic intermediate manufacturing.
Novel soluble solid-phase carrier technology reduces solvent waste and reactor size for scalable polypeptide drug production like Eptifibatide.
Analyzing patent CN101712716A for Vapreotide production. Highlights solid-phase iodine oxidation for higher yield and cost reduction in API manufacturing.
Patent CN114276411B reveals a solid-phase method for trisulfide cyclic peptides. Achieve high purity and yield with scalable manufacturing for pharmaceutical intermediates.
Novel liquid-phase side chain synthesis reduces costs and improves purity for Tirzepatide manufacturing, offering significant supply chain advantages for global pharmaceutical partners.